J1411 HCPCS Level II code: Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
J1411 is the HCPCS code for “Injection, etranacogene dezaparvovec-drlb, per therapeutic dose” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1411Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
Short description: Inj, hemgenix, per tx dose
HCPCS · United States
Medicare details
The indicators CMS publishes with J1411 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Apr 1, 2023
Where J1411 sits
- 1J codesDrugs administered other than orally
- 2Active code J1411Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1411 mean?
J1411 is the HCPCS code for “Injection, etranacogene dezaparvovec-drlb, per therapeutic dose” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1411?
CMS lists J1411’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1411
All J codesJ1330Injection, ergonovine maleate, up to 0.2 mgJ1335Injection, ertapenem sodium, 500 mgJ1364Injection, erythromycin lactobionate, per 500 mgJ1370Injection, esomeprazole sodium, 1 mgJ1380Injection, estradiol valerate, up to 10 mgJ1410Injection, estrogen conjugated, per 25 mgJ1412Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomesJ1413Injection, delandistrogene moxeparvovec-rokl, per therapeutic doseJ1414Injection, fidanacogene elaparvovec-dzkt, per therapeutic doseJ1426Injection, casimersen, 10 mgJ1427Injection, viltolarsen, 10 mgJ1428Injection, eteplirsen, 10 mg